White Willow: Benefits, Dosage, Contraindications

Updated on

The willow is a tree of the Salicaceae family that can reach 25 m in height. It is common in the Northern Hemisphere, across Europe, North America, and Asia, particularly in wet areas at the edges of waterways. Willow bark was commonly used in the time of Hippocrates. Patients were advised to chew the bark to relieve pain and fever. The salicin, a component of willow bark discovered in 1831, acts as a precursor to salicylic acid in the body. In phytotherapy, the dried bark of young twigs must contain at least 1.5% salicylate derivatives, expressed as salicin. Salicylic acid, derived from the oxidation of salicin, was used as early as the mid-19th century, but its use was limited due to its irritating effects on the stomach. In 1853, a French chemist modified salicylic acid to create acetylsalicylic acid but did not pursue its development. In 1897, Felix Hoffmann, a chemist at Bayer, rediscovered this substance in the treatment of rheumatoid arthritis. Two years later, Bayer marketed Aspirin. Since then, it has become one of the most used drugs in the world. Contrary to popular belief, aspirin was developed from the salicin of meadowsweet and not from willow bark. Willow bark works very similarly to aspirin. Thus, it is used for pain, notably headaches, muscle or joint pain, menstrual cramps, arthritis, osteoarthritis, gout, and more generally for inflammatory rheumatism.

Other name(s) 

a:0:{}

Scientific name(s)

Salix Alba

Family or group: 

Plants

Active ingredients:

Salicin


Indications

Rating methodology

EFSA approval.

Several clinical trials (> 2) randomized controlled with double blind, including a significant number of patients (>100) with consistently positive outcomes for the indication.
Several clinical trials (> 2) randomized controlled with double blind, and including a significant number of patients (>100) with positive outcomes for the indication.
One or more randomized studies or multiple cohorts or epidemiological studies with positive outcomes for the indication.
Clinical studies exist but are uncontrolled, with conclusions that may be positive or contradictory.
Lack of clinical studies to date that can demonstrate the indication.


Lower back pain
✪✪✪✪✪

It has been shown that taking a daily willow bark extract providing 120-240 mg of salicin can reduce lower back pain in some patients. The higher concentration of 240 mg of salicin is more effective than 120 mg of salicin. Significant relief may take up to a week. Some research suggests that 240 mg of salicin per day is as effective as conventional treatments for low back pain. The willow bark extract 393-1600 mg providing 120-240 mg of salicin was used daily for 4 weeks.

Posologie

posologieOral: bark

posologie393 - 1600 mg

duration4 - weeks

formulationstandardized extract


Osteoarthritis
✪✪✪✪✪

Clinical research on willow bark extract for osteoarthritis remains conflicting today. Some preliminary clinical research shows that taking a willow bark extract standardized to contain 120-240 mg of salicin per day for 2 to 6 weeks produces moderate analgesic activity compared to placebo in patients with osteoarthritis, while improving swelling, tenderness, and physical function. However, other research shows that taking willow bark standardized to 240 mg of salicin per day for 6 weeks does not improve pain, stiffness, or physical function compared to placebo in patients with osteoarthritis. Further studies will be necessary to assess the effectiveness of willow bark extracts in the treatment of osteoarthritis.

Posologie

posologieOral: bark

posologie393 - 1600 mg

duration6 - weeks

formulationstandardized extract


Rheumatoid arthritis
✪✪✪✪✪

Due to its anti-inflammatory and analgesic properties, willow bark may be recommended for inflammatory rheumatisms. However, preliminary clinical research suggests that willow bark extract is not effective against rheumatoid arthritis. Further studies will be necessary to validate these results.

Posologie

posologieOral: bark

posologie393 - 1600 mg

formulationstandardized extract


Properties


Analgesic

full-leaffull-leaffull-leaffull-leaf

When ingested, willow bark extracts inhibit the production of certain inflammatory substances (prostaglandins) via the cyclooxygenase enzyme (COX)-2 pathway, without directly affecting COX-1 or COX-2 enzymes. Salicin, converted into salicylic acid in the body, is responsible for this effect. Other components of willow bark may also play a role in inhibiting other inflammatory pathways and providing antioxidant effects, thereby contributing to the analgesic effect. Clinical studies have validated the effectiveness of these extracts for treating osteoarthritis and chronic lower back pain.

Usages associés

Migraine, Flu, Lower back pain, Joint pain, Cold, Rheumatoid arthritis, Osteoarthritis

Anti-inflammatory

full-leaffull-leaffull-leafempty-leaf

Clinical studies have shown that willow bark extracts, particularly those standardized in salicin, possess anti-inflammatory and analgesic properties. These extracts inhibit certain enzymes and inflammatory substances in the body, such as prostaglandins. Besides salicin, other components of willow bark, such as flavonoids and polyphenols, also contribute to these effects. Tests on animal models indicated that willow extract is at least as effective as aspirin in reducing inflammation and could be gentler on the stomach.

Usages associés

Migraine, Flu, Lower back pain, Joint pain, Cold, Rheumatoid arthritis, Osteoarthritis

Antiplatelet/Anticoagulant

full-leaffull-leafempty-leafempty-leaf

White willow has antiplatelet properties due to salicin, a precursor to salicylic acid, but to a lesser degree than aspirin.


Safety dosage

Adult from 18 years: 480 mg - 1200 mg (dry extract)

To be consumed only by adults (dry extract estimated at 15% Salicin). - Herbal tea: 1 to 3 g of crushed plant substance in 150 ml boiling water, infused 3 times a day. - Decoction: 4 g of crushed plant substance are added to a cup (200 ml) of water and boiled covered for 15 minutes. Let sit for 15 minutes, then strain. Drink after meals, 3 times a day, a glass of freshly prepared hot decoction. - Plant powder: 260-500 mg 3-8 times a day. To be taken after meals. It is advised to take it with a larger amount of hot water. - Dry aqueous extract (8-20:1): 600 mg twice a day - Dry aqueous extract (16-23:1): 480 mg twice a day - Tincture (1:5): 15-24 ml per day


Interactions

Médicaments

Acetazolamide: weak interaction

Willow bark contains salicin, a plant salicylate. Human case reports suggest that a combination of acetazolamide and salicylate increases plasma levels of unbound acetazolamide as well as acetazolamide-related adverse effects. Theoretically, willow bark could result in additive adverse effects associated with acetazolamide.

Antiplatelet/Anticoagulant: strong interaction

Concomitant use could theoretically increase the risk of bleeding due to decreased platelet aggregation. Willow bark has antiplatelet effects, but less so than aspirin. Avoid concurrent use with other anticoagulant and antiplatelet medications. Some of these include aspirin, clopidogrel, dalteparin, enoxaparin, heparin, ticlopidine, warfarin, and others.

Aspirin: moderate interaction

Willow bark contains salicin, a plant salicylate. Theoretically, willow bark could have an additive effect with other medications containing salicylate such as aspirin.

Magnesium trisalicylate: weak interaction

Willow bark contains salicin, a plant salicylate. Theoretically, willow bark could have an additive effect with other medications containing salicylate such as choline magnesium trisalicylate.

Salsalate: moderate interaction

Willow bark contains salicin, a plant salicylate. Theoretically, willow bark could have an additive effect with other medications containing salicylate such as salsalate.

Non-steroidal anti-inflammatory drug: moderate interaction

Concomitant use with salicylates and other NSAIDs is not recommended without medical advice.

Plantes ou autres actifs

Antiplatelet/Anticoagulant: weak interaction

The salicin in white willow and anticoagulant supplements have additive effects. Avoid concurrent intake which could increase bleeding risks.

White willow: weak interaction

Theoretically, concurrent use may potentiate salicylate effects and adverse effects.

White willow: weak interaction

Theoretically, concurrent use may potentiate salicylate effects and adverse effects.


Precautions

Allergies: avoid

As a precautionary principle, willow is not recommended for individuals with hypersensitivity to acetylsalicylic derivatives (0.2% of the population).

Gastric ulcer: avoid

Contraindicated in cases of active gastro-duodenal ulcer.


Contraindications

Child up to 18 years: prohibited

Use in children and adolescents under 18 years is contraindicated due to the risk of Reye's syndrome.

Pregnant woman: prohibited

Use during the first and second trimesters of pregnancy and during breastfeeding is not recommended. Salicylates cross the placenta and pass into breast milk.

Breastfeeding woman: prohibited

Use during the first and second trimesters of pregnancy and during breastfeeding is not recommended. Salicylates cross the placenta and pass into breast milk.

G6PD deficiency: prohibited

Glucose-6-phosphate dehydrogenase deficiency or Favism.

Renal insufficiency: prohibited

Severe liver or kidney dysfunction.

Hepatic insufficiency: prohibited

Severe liver or kidney dysfunction.

Coagulation disorder: prohibited

Risk of bleeding.

Reye's syndrome: prohibited

A medical history of Reye's syndrome is a contraindication.